17-alpha-hydroxyprogesterone has been researched along with Hypoadrenocorticism, Familial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, GH; Koh, JW; Yoo, HW; Yu, J | 1 |
| Ali, JM; Harun, F; Jalaludin, MY | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Hypoadrenocorticism, Familial
| Article | Year |
|---|---|
Clinical features of congenital adrenal insufficiency including growth patterns and significance of ACTH stimulation test.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Adrenocorticotropic Hormone; Bone Development; Child; Child, Preschool; DAX-1 Orphan Nuclear Receptor; Disorder of Sex Development, 46,XY; Female; Genetic Diseases, X-Linked; Genotype; Glucocorticoids; Humans; Hypoadrenocorticism, Familial; Intellectual Disability; Male; Mineralocorticoids; Obesity; Phosphoproteins; Puberty, Precocious; Retrospective Studies; Steroid 21-Hydroxylase | 2013 |
Late onset X-linked adrenal hypoplasia congenita with hypogonadotropic hypgonadism due to a novel 4-bp deletion in exon 2 of NR0B1.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Age of Onset; Child; DAX-1 Orphan Nuclear Receptor; Exons; Genetic Diseases, X-Linked; Humans; Hypoadrenocorticism, Familial; Hypogonadism; Male; Mutation; Pedigree; Prognosis; Sequence Deletion | 2014 |